Showing results (1681-1690 of 2,482) with videos related to
Sort By:
Pageof 249
Clinical and Translational Science|April 30, 2022
A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalenceScott A Mosley, Sarah Kim, Nihal El Rouby, et al.Clinical and Translational Science|April 6, 2022
Pharmacogenetic testing among patients with depression in a US managed care populationHeather D Anderson, Thida M Thant, David P Kao, et al.Clinical and Translational Science|July 27, 2022
A drug-disease model for predicting survival in an Ebola outbreakMasood Khaksar Toroghi, Nidal Al-Huniti, John D Davis, et al.Clinical and Translational Science|April 12, 2023
Model-informed approach to support pediatric dosing for the pan-PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumorsPeter N Morcos, Jan Schlender, Rolf Burghaus, et al.Clinical and Translational Science|May 13, 2023
A leucine-rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson's disease with and without LRRK2 mutations and healthy controlsMaurits F J M Vissers, Matthew D Troyer, Eva Thijssen, et al.Clinical and Translational Science|May 8, 2023
A long-acting GDF15 analog causes robust, sustained weight loss and reduction of food intake in an obese nonhuman primate modelSongmao Zheng, David Polidori, Yuanping Wang, et al.Clinical and Translational Science|May 9, 2023
Digital technologies: Innovations that transform the face of drug developmentElena S Izmailova, Bilal AbuAsal, Hazem E Hassan, et al.Clinical and Translational Science|August 22, 2020
A Dynamic Quantitative Systems Pharmacology Model of Inflammatory Bowel Disease: Part 2 - Application to Current Therapies in Crohn's DiseaseKatharine V Rogers, Steven W Martin, Indranil Bhattacharya, et al.Clinical and Translational Science|March 26, 2021
A population pharmacodynamic Markov mixed-effects model for determining remimazolam-induced sedation when co-administered with fentanyl in procedural sedationJie Zhou, Laura Curd, Lauren R L Lohmer, et al.Clinical and Translational Science|March 31, 2021
Adverse drug event risk assessment by the virtual addition of COVID-19 repurposed drugs to Medicare and commercially insured patients' drug regimens: A drug safety simulation studyMatt K Smith, Ravil Bikmetov, Sweilem B Al Rihani, et al.Pageof 249